What’s Driving Lung Cancer in Nonsmokers?
What’s Driving Lung Cancer in Nonsmokers? Understanding RET-Positive Lung Cancer
Lung cancer isn’t just a smoker’s disease. In fact, up to 20% of lung cancer patients have never smoked, and many are younger women. One reason? Genetic mutations like RET fusions, which can drive cancer growth even without traditional risk factors. This type, called RET-positive lung cancer, is more common in never smokers and doesn’t show up on routine screenings.
That’s why genetic testing (also called biomarker testing) is critical. It can help doctors choose targeted treatments that work better and offer more hope—especially for patients with stage 4 or hard-to-treat lung cancer. Even if you’ve never smoked, if you’re experiencing unusual symptoms or have lung cancer in your family, talk to your doctor about testing. Early detection and personalized care are changing what’s possible. (Source: American Cancer Society, Yale Medicine, J Clin Oncol)
Young Mom Beats Lung Cancer Odds
Just as 38-year-old Lauren was getting back into shape after becoming a new mom, her life changed overnight. A nagging pain in her neck led to scans that uncovered a mass in her lung—stage 3 lung cancer. She went from running miles to navigating CT scans and the shock of a diagnosis she never imagined. “I remember saying, ‘Am I going to make it to my daughter Elle’s second birthday?’” Lauren recalled.
Motivated by her young daughter, Lauren faced treatment head-on. She preserved her fertility, then began chemotherapy and radiation to shrink the tumors. A portion of her lung was surgically removed after a month of healing. Throughout it all, she clung to her purpose: “Elle gave me the motivation to get up and get infusions when I was feeling my worst.” Genetic testing revealed an EGFR mutation—common in nonsmokers like Lauren and a key to unlocking targeted therapy. Now, with no evidence of disease, Lauren stays vigilant with regular scans and remains a voice of hope.
“Your support literally saves lives,” she says, grateful for both friends and strangers who make research breakthroughs possible. (Source: GO2 for Lung Cancer)
Breaking the Stigma Around Lung Cancer
More than half of people with lung cancer report feeling judged or blamed by friends, family, and even healthcare providers. Because lung cancer has long been linked to smoking, many assume it’s the patient’s fault. But the reality is different: anyone with lungs can develop lung cancer, including those who have never smoked or who quit years ago.
Stigma doesn’t just hurt feelings—it can actually keep people from getting screened or treated promptly, harming their health. Experts emphasize that lung cancer is no one’s fault; nicotine addiction is difficult to overcome, and no patient deserves blame. Recognizing and reducing lung cancer stigma helps ensure all patients receive the compassion and medical support they deserve. (Source: Memorial Sloan Kettering)
Lung Cancer in Women and Non-Smokers: What to Know
Lung cancer diagnoses are declining overall—but among people under 65, women now have higher incidence rates than men, according to the American Cancer Society. Many of these women have never smoked. In fact, mutations like EGFR, which are more common in women and especially Asian women, are driving a growing number of lung cancer cases in people who don’t fit the traditional image of a patient. Yet outdated stereotypes still delay diagnosis: younger, nonsmoking women are often misdiagnosed with asthma or bronchitis, losing precious time before receiving life-saving treatment.
Thanks to advances in genetic testing, targeted therapies, and early screening, lung cancer survival is improving. But too many people—especially women—are still dismissed or overlooked simply because they don’t “look” like a typical patient. If you feel something is wrong, trust yourself. Anybody with lungs can get lung cancer. The sooner it’s caught, the better the outcome. Learn more about the symptoms, risk factors, and how to advocate for the care you deserve. (Source: Memorial Sloan Kettering Cancer Center)




